Entera Bio Ltd. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Entera Bio Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q2 2024.
  • Entera Bio Ltd. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $20K, a 300% increase year-over-year.
  • Entera Bio Ltd. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $69K, a 1050% increase year-over-year.
  • Entera Bio Ltd. annual Nonoperating Income (Expense) for 2023 was $31K, a 62.7% decline from 2022.
  • Entera Bio Ltd. annual Nonoperating Income (Expense) for 2022 was $83K.
  • Entera Bio Ltd. annual Nonoperating Income (Expense) for 2021 was -$29K, a 3.57% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $69K $20K +$15K +300% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $54K $45K +$23K +105% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $31K -$32K -$19K -146% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $50K $36K +$44K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $6K $5K -$55K -91.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $61K $22K -$22K -50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $83K -$13K +$14K +51.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $69K -$8K -$1K -14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $70K $60K +$84K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$14K $44K +$15K +51.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$29K -$27K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$7K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$24K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $29K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.